Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

1.6K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.6K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

6.2K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
6.2K
Dialysis01:27

Dialysis

2.0K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.0K
Dialysis01:15

Dialysis

2.2K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.2K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

846
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
846
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rescue Therapy With Pegcetacoplan in a Patient With Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits.

Kidney international reports·2026
Same author

Benefits of an Innovative 90-Day Longevity Workplace Program on Health in the United Arab Emirates (UAE).

International journal of environmental research and public health·2025
Same author

Real-World Prescribing of Renal and Cardiovascular Protective Drugs in Patients With Type 2 Diabetes and Chronic Kidney Disease: Analysis of Data From a Western Australian Quaternary Hospital.

Heart, lung & circulation·2025
Same author

Simultaneous Measurement of Calciprotein Particles with Different Assays and Clinical Outcomes in CKD.

Kidney360·2025
Same author

The formation and function of calciprotein particles.

Pflugers Archiv : European journal of physiology·2025
Same author

Projecting the clinical burden of chronic kidney disease at the patient level (<i>Inside CKD</i>): a microsimulation modelling study.

EClinicalMedicine·2024

Related Experiment Video

Updated: Mar 28, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K

Peritoneal Dialysis for Heart Failure.

Harish Puttagunta1, Stephen G Holt2

  • 1Royal Melbourne Hospital, Melbourne, Australia.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|December 25, 2015
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis (PD) offers a potentially cost-effective ultrafiltration (UF) therapy for heart failure (HF) patients with renal impairment. Further research is needed to confirm its benefits and medicoeconomic advantages for this complex patient group.

Keywords:
Peritoneal dialysiscardiorenalelderlyheart failureultrafiltration

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.9K

Related Experiment Videos

Last Updated: Mar 28, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.9K

Area of Science:

  • Nephrology
  • Cardiology
  • Geriatrics

Background:

  • Heart failure (HF) is a significant cause of morbidity and mortality in the elderly.
  • Increasing survival rates for ischemic heart disease have led to a rise in prevalent HF cases.
  • Renal impairment complicates HF management and limits traditional therapies.

Purpose of the Study:

  • To examine the use of peritoneal dialysis (PD) for ultrafiltration (UF) therapy in heart failure patients with renal impairment.
  • To evaluate the potential benefits and challenges of PD in this specific patient population.
  • To explore the medicoeconomic advantages of PD compared to other UF techniques.

Main Methods:

  • Review of existing literature on ultrafiltration techniques for heart failure.
  • Analysis of the application and efficacy of peritoneal dialysis (PD) in selected HF patients.
  • Discussion of the challenges in demonstrating PD's benefits to cardiologists.

Main Results:

  • Ultrafiltration (UF) techniques show promise for diuretic-resistant heart failure.
  • Extracorporeal treatments' early successes in UF have not been consistently confirmed in randomized trials.
  • Peritoneal dialysis (PD) may offer a cheaper and more effective UF therapy option for selected patients.

Conclusions:

  • Peritoneal dialysis (PD) presents a potential alternative for ultrafiltration in heart failure patients with renal impairment.
  • A combined strategy of demonstrating individual case improvements and studying medicoeconomic benefits is crucial for wider adoption by cardiologists.
  • Further research is warranted to solidify the role of PD in managing complex heart failure cases.